文献速递腹部技术与安全

遗传性与散发性胰腺导管腺癌的遗传学与影像学进展

Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.
PubMed 文献 · Radiol Imaging Cancer · 2020-03-13

本文综述胰腺导管腺癌(PDAC)的遗传学格局及其前驱病变,回顾易感PDAC的遗传性综合征,并讨论影像学在筛查与分期评估中的当前作用,以及分子肿瘤靶向成像在PDAC及其前驱病变评估中的潜在价值。

要点

  • PDAC起源于微观和宏观前驱病变的多步骤进展,由累积遗传异常驱动。
  • BRCA1、BRCA2、PRSS1及错配修复基因胚系突变易感PDAC。
  • Lynch综合征可发生罕见「髓样」腺癌变异型,McCune-Albright综合征可见导管内乳头状黏液性肿瘤。

临床应用与阅片要点

  • 了解PDAC的遗传学格局和前驱病变的多步骤进展,有助于理解肿瘤生物学并关联诊断、管理与预后。
  • 识别易感PDAC的遗传性综合征(如BRCA1/BRCA2、PRSS1、错配修复基因突变、Lynch综合征、McCune-Albright综合征)对评估患者风险有潜在意义。
  • 影像学在PDAC筛查和分期评估中具有当前作用,分子肿瘤靶向成像在PDAC及其前驱病变评估中具有潜在作用。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic ductal adenocarcinoma (PDAC) is a genetically heterogeneous, biologically aggressive malignancy with a uniformly poor prognosis. While most pancreatic cancers arise sporadically, a small subset of PDACs develop in patients with hereditary and familial predisposition. Detailed studies of the rare hereditary syndromes have led to identification of specific genetic abnormalities that contribute to malignancy. For example, germline mutations involving BRCA1, BRCA2, PRSS1, and mismatch repair genes predispose patients to PDAC. While patients with Lynch syndrome develop a rare "medullary" variant of adenocarcinoma, intraductal papillary mucinous tumors are observed in patients with McCune-Albright syndrome. It is now well established that PDACs originate via a multistep progression from microscopic and macroscopic precursors due to cumulative genetic abnormalities. Improved knowledge of tumor genetics and oncologic pathways has contributed to a better understanding of tumor biology with attendant implications on diagnosis, management, and prognosis. In this article, the genetic landscape of PDAC and its precursors will be described, the hereditary syndromes that predispose to PDAC will be reviewed, and the current role of imaging in screening and staging assessment, as well as the potential role of molecular tumor-targeted imaging for evaluation of patients with PDAC and its precursors, will be discussed. Keywords: Abdomen/GI, Genetic Defects, Oncology, Pancreas Supplemental material is available for this article. © RSNA, 2020.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Morani AC, Hanafy AK, Ramani NS, et al. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Radiol Imaging Cancer. 2020. PMID: 33778702. doi:10.1148/rycan.2020190020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。